CrossBridge Bio
- Biotech or pharma, therapeutic R&D
CrossBridge Bio is a Houston-based biotechnology company pioneering next-generation dual-payload antibody-drug conjugates (ADCs).
Our proprietary EGCit stable, enzymatically cleavable linker enables site-specific attachment of two complementary payloads to a single antibody, delivering synergistic anti-tumor activity while greatly reducing off-target toxicity.
CrossBridge Bio welcomes partnering opportunities to apply our dual-payload platform to external antibodies and to co-develop differentiated ADC assets that address tumor heterogeneity and therapeutic resistance.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}